⚠️ This provider averages 1.5K services per working day — physically unusual for an individual practitioner
Based on 3.7M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $48.9M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.
Averaging 1.5K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 392% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 58% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $44.52 | $15.30 | 2.91x | $29.22 | $1.3M | 85.0K | 37 |
| 2015 | $43.11 | $13.37 | 3.22x | $29.74 | $2.0M | 153.3K | 39 |
| 2016 | $42.61 | $11.44 | 3.72x | $31.17 | $3.0M | 260.2K | 41 |
| 2017 | $48.21 | $13.28 | 3.63x | $34.93 | $3.7M | 275.8K | 43 |
| 2018 | $55.48 | $14.90 | 3.72x | $40.58 | $5.4M | 361.0K | 46 |
| 2019 | $56.13 | $14.66 | 3.83x | $41.47 | $5.4M | 365.9K | 43 |
| 2020 | $54.39 | $14.13 | 3.85x | $40.26 | $7.8M | 548.6K | 44 |
| 2021 | $52.30 | $12.35 | 4.23x | $39.95 | $7.2M | 584.8K | 42 |
| 2022 | $57.65 | $11.84 | 4.87x | $45.81 | $6.8M | 574.2K | 40 |
| 2023 | $62.02 | $12.27 | 5.05x | $49.75 | $6.4M | 522.1K | 38 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 1.1M | $15.4M | $14.47 | 5.03x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 175.5K | $6.8M | $38.50 | 3.72x |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 954.8K | $5.3M | $5.52 | 4.14x |
| J0897 | Injection, denosumab, 1 mg | 296.1K | $4.5M | $15.12 | 3.33x |
| J3262 | Injection, tocilizumab, 1 mg | 776.5K | $3.0M | $3.83 | 3.67x |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 53.0K | $2.9M | $53.95 | 3.93x |
| J9312 | Injection, rituximab, 10 mg | 25.9K | $1.8M | $68.87 | 3.78x |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 165.5K | $1.2M | $7.36 | 3.53x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 11.2K | $1.1M | $98.85 | 3.25x |
| 76881 | Complete ultrasound scan of joint | 18.4K | $1.0M | $56.20 | 4.79x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 12.4K | $1.0M | $82.02 | 2.64x |
| J9310 | Injection, rituximab, 100 mg | 1.1K | $732.9K | $645.75 | 3.80x |
| J3357 | Ustekinumab, for subcutaneous injection, 1 mg | 4.4K | $653.9K | $148.17 | 2.22x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 11.5K | $639.0K | $55.53 | 3.06x |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 3.2K | $354.9K | $111.44 | 2.78x |
| J3245 | Injection, tildrakizumab, 1 mg | 2.8K | $308.9K | $110.31 | 3.37x |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | 3.7K | $248.8K | $67.68 | 4.99x |
| 73130 | X-ray of hand, minimum of 3 views | 9.4K | $223.3K | $23.88 | 3.38x |
| 73100 | X-ray of wrist, 2 views | 8.9K | $203.8K | $22.94 | 3.10x |
| 73630 | X-ray of foot, minimum of 3 views | 8.5K | $193.7K | $22.79 | 3.28x |
This provider submits charges 4.11 times higher than what Medicare actually pays.
A markup ratio of 4.11x means for every $100 Medicare pays, this provider initially charges $411. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Rheumatology providers in LA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Larry Broadwell, MD | Shreveport, LA | $53.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data